← Leaderboards
Eduardo J Martinez
Medros, Inc.
$566,029
Attributed
$566,029
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $296.5K · FY2007–08$500K$375K$250K$125K$0
'07
'08
Funding mix
By agency
NIH$566,029 · 4
By mechanism
R43$401,729 · 3
R41$164,300 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cost”
- Eric S Lander · Whitehead Institute For Biomedical Res$748,368,930
- Richard K. Wilson · Washington University$429,230,873
- Richard A Gibbs · Baylor College Of Medicine$414,258,216
- David R. Weir · University Of Michigan At Ann Arbor$393,741,481
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Research focus
CostDrug DiscoverySafetyScreening ProcedureClinicDrug Evaluation, PreclinicalPharmaceutical PreparationsRateToxic EffectBasePre-Clinical ModelDrosophila GenusMedicalDiabetes MellitusMedullary Carcinoma Of ThyroidCountryMarketingNeoplasm MetastasisComplexLeadLibrariesClinical Trials, Phase IiiBasic ScienceMalignant Neoplasms
Grant awards (4)
Assessing Concentration Levels of Pharmacological Agents in Drosophila$137,071
R43 · FY2008 · GM · contact PI
High Throughput Lethality Screen in Drosophila Against Tumor Metastasis$132,480
R43 · FY2008 · CA · contact PI
High Throughput Drug Screening in Drosophila for Novel Diabetes Therapeutics$164,300
R41 · FY2007 · DK · contact PI
High Throughput Drug Screening in Drosophila for Novel Cancer Therapeutics$132,178
R43 · FY2007 · CA · contact PI